Covidence_num,OutcomeCategory,StandardizedRF,RFCategory,StdEffect
#260,AD,a1-antichymotrypsin signal peptide 215A/T polymorphism,Genomic,increase risk
#169,AD,Alpha-1-antichymotrypsin (ACT)-17(A>T) polymorphisms,Genomic,Increase risk
#366,AD,ABCA1 rs2066718 and rs1800977,Genomic,not significant
#366,AD,ABCA1 rs2422493,Genomic,Increase risk
#527,AD,ATP-binding cassette transporter A1 (ABCA1),Genomic,Not significant
#419,AD,AD-linc1,Genomic,Increase risk
#419,AD,AD-linc2,Genomic,Increase risk
#555,AD,amyloid beta,Biomarker,Increase risk
#868,AD,amyloid beta-40,Biomarker,increase risk
#868,AD,amyloid beta-42,Biomarker,increase risk
#641,AD,Amyloid-beta removal,Medication,Not significant
#229,AD,apoe,Genomic,decrease risk
#402,dementia,apoe,Genomic,Increase risk
#495,vascular dementia,ApoE,Genomic,increase risk
#495,vascular dementia,ApoE,Genomic,increase risk
#952,dementia,apoe,Genomic,Increase risk
#180,AD,APOE e2,Genomic,not significant
#375,AD,APOE e2,Genomic,Not significant
#567,AD,APOE e2,Genomic,Decrease risk
#180,AD,ApoE e2/3,Genomic,not significant
#180,AD,ApoE e2/4,Genomic,increase risk
#180,AD,ApoE e2/4,Genomic,decrease risk
#180,AD,APOE e3,Genomic,decrease risk
#375,AD,APOE e3,Genomic,Decrease risk
#180,AD,ApoE e3/4,Genomic,increase risk
#180,AD,ApoE e3/4,Genomic,decrease risk
#106,AD,APOE e4,Genomic,Increase risk
#180,AD,APOE e4,Genomic,increase risk
#375,AD,APOE e4,Genomic,Increase risk
#513,Dementia,APOE e4,Genomic,Increase risk
#716,AD,APOE e4,Genomic,Increase risk
#857,AD,APOE e4,Genomic,increase risk
#980,AD,APOE e4,Genomic,Increase risk
#180,AD,ApoE e4/4,Genomic,increase risk
#938,dementia,modifiable risk factors associated with APOE e4,Genomic,Not significant
#273,AD,rs12989701 BIN1,Genomic,Increase risk
#273,AD,rs744373 BIN1,Genomic,Increase risk
#424,AD,rs744373 BIN1,Genomic,Increase risk
#308,AD,ESR1 PvuII polymorphism,Genomic,decrease risk
#308,AD,ESR1 XbaI polymorphism,Genomic,not significant
#266,AD,IL-10 gene polymorphism,Genomic,increase risk
#266,AD,IL-10 gene polymorphism,Genomic,increase risk
#273,AD,IL-1A rs1800587,Genomic,Increase risk
#273,AD,IL-1B rs1143634,Genomic,Increase risk
#317,AD,IL-6-174G/C polymorphism,Genomic,Increase risk
#354,AD,il-6-174g/c polymorphism,Genomic,Not significant
#756,AD,interleukin-8 gene polymorphism,Genomic,increase risk
#419,AD,LncRNA 17A,Genomic,Increase risk
#419,AD,long non-coding RNA,Genomic,Increase risk
#419,AD,long non-coding RNAs(BC200),Genomic,Increase risk
#419,AD,long non-coding RNAs(EBF3-AS),Genomic,Increase risk
#403,AD,vegf-1154g/a,Genomic,Not significant
#403,AD,vegf-2578c/a,Genomic,Not significant
#207,AD,ACE gene I/D polymorphism,Genomic,Increase risk
#1132,dementia,acetylcholinesterase inhibitors,Medication,Decrease risk
#588,AD,acetylcholinesterase inhibitors,Medication,Not significant
#405,vascular dementia,activated factor VII,Biomarker,Increase risk
#934,Dementia,activity,Life style,Decrease risk
#471,AD,adherence to healthy diet,Life style,Increase risk
#442,AD,adiposity,Condition,Not significant
#164,Dementia,affective disorders,Condition,Increase risk
#157,dementia,age,Demographic,Increase risk
#425,AD,age,Demographic,Increase risk
#567,AD,age,Demographic,Increase risk
#655,dementia,age,Demographic,inconsistent
#857,AD,age,Demographic,increase risk
#952,dementia,age,Demographic,Increase risk
#250,AD,Agreeableness,Life style,decrease risk
#1021,Dementia,Air Pollution,Environment,Decrease risk
#401,dementia,Air pollution,Environment,increase risk
#458,AD,air pollution,Environment,Increase risk
#553,dementia,Air Pollution,Environment,Increase risk
#274,dementia,Alcohol,Life style,inconsistent
#298,Dementia,Alcohol,Life style,Decrease risk
#298,Dementia,Alcohol,Life style,Increase risk
#435,dementia,Alcohol,Life style,Decrease risk
#435,VaD,Alcohol,Life style,Decrease risk
#435,AD,Alcohol,Life style,Decrease risk
#486,Dementia,Alcohol,Life style,Increase risk
#487,dementia,Alcohol,Life style,Increase risk
#566,AD,Alcohol,Life style,Decrease risk
#567,AD,Alcohol,Life style,Decrease risk
#655,dementia,Alcohol,Life style,inconsistent
#1049,AD,alpha-lipoic acid (ALA),Medication,Decrease risk
#1058,AD,Aluminum,Environment,Increase risk
#553,dementia,aluminum,Environment,Increase risk
#823,dementia,Androgen deprivation therapy,Medication,Increase risk
#347,AD,anesthesia,Procedure,not significant
#655,dementia,Angina,Condition,inconsistent
#87,AD,angiotensin converting enzyme inhibitor,Medication,decrease risk
#766,AD,Angiotensin receptor blocker,Medication,decrease risk
#87,AD,angiotensin receptor blocker,Medication,decrease risk
#963,dementia,ankle-brachial index,Biomarker,Increase risk
#435,AD,Anti- inflammatories ,Medication,Decrease risk
#834,AD,anti-amyloid-b immunotherapy,Medication,Decrease risk
#834,AD,anti-amyloid-b immunotherapy,Medication,Decrease risk
#834,AD,anti-amyloid-b immunotherapy,Medication,Decrease risk
#487,dementia,anticholinergic drugs,Medication,Not significant
#914,AD,anticholinergic drugs,Medication,Increase risk
#1048,Dementia,Anticoagulation,Medication,Decrease risk
#1185,dementia,antihypertensive medication,Medication,Decrease risk
#25,Dementia,antihypertensive medication,Medication,Not significant
#435,dementia,antihypertensive medication,Medication,Decrease risk
#435,AD,antihypertensive medication,Medication,Not significant
#487,dementia,antihypertensive medication,Medication,Decrease risk
#519,Dementia,antihypertensive medication,Medication,Decrease risk
#519,AD,antihypertensive medication,Medication,Decrease risk
#519,Vascular dementia,antihypertensive medication,Medication,Decrease risk
#529,dementia,antihypertensive medication,Medication,Decrease risk
#532,dementia,antihypertensive medication,Medication,Not significant
#532,AD,antihypertensive medication,Medication,Decrease risk
#566,AD,antihypertensive medication,Medication,Decrease risk
#274,dementia,Antioxidant,Biomarker,inconsistent
#435,dementia,antioxidants,Medication,Decrease risk
#1270,dementia,anxiety,Condition,Not significant
#1270,AD,Anxiety,Condition,Not significant
#1270,Dementia,Anxiety,Condition,Not significant
#1270,AD,anxiety,Condition,Not significant
#284,dementia,Anxiety,Condition,increase risk
#345,dementia,Anxiety,Condition,increase risk
#350,dementia,anxiety,Condition,Increase risk
#412,dementia,anxiety,Condition,Increase risk
#427,vascular dementia,Anxiety,Condition,Increase risk
#502,dementia,Anxiety,Condition,Increase risk
#502,dementia,anxiety,Condition,Increase risk
#502,Dementia,Anxiety,Condition,Increase risk
#502,dementia,anxiety,Condition,Increase risk
#103,dementia,arachidonic acid,Biomarker,not significant
#566,AD,arthritis,Condition,Decrease risk
#225,Dementia,atherosclerosis,Condition,Increase risk
#1069,dementia,atrial fibrillation,Condition,Increase risk
#171,AD,atrial fibrillation,Condition,Increase risk
#225,Dementia,atrial fibrillation,Condition,Increase risk
#435,dementia,Atrial fibrillation ,Condition,Increase risk
#435,AD,Atrial fibrillation ,Condition,Not significant
#422,Dementia,being married,Life style,Decrease risk
#422,Dementia,being married,Life style,Increase risk
#1263,Dementia,Benzodiazepine,Medication,Increase risk
#435,dementia,benzodiazepine,Medication,Not significant
#481,dementia,benzodiazepine,Medication,increase risk
#277,dementia,bilingualism,Demographic,Not significant
#435,Dementia,bilingualism,Demographic,Not significant
#418,dementia,Bipolar disorder,Condition,Increase risk
#641,AD,Blocking Amyloid-beta signaling,Medication,Not significant
#641,AD,Blocking tau-Mediated toxicity,Medication,Not significant
#1006,dementia,body mass index,Condition,Not significant
#208,AD,body mass index,Condition,Increase risk
#217,dementia,body mass index,Condition,Increase risk
#231,AD,body mass index,Condition,increase risk
#423,dementia,body mass index,Condition,Increase risk
#435,VaD,body mass index,Condition,Increase risk
#435,dementia,body mass index,Condition,Increase risk
#435,AD,body mass index,Condition,Increase risk
#566,AD,Body mass index,Condition,Increase risk
#566,AD,Body mass index,Condition,Decrease risk
#566,AD,Body mass index,Condition,Increase risk
#655,dementia,Bone mineral density,Biomarker,inconsistent
#888,AD,Bone mineral density,Biomarker,increase risk
#888,AD,Bone mineral density,Biomarker,increase risk
#1038,AD,Brain-derived neurotrophic factor,Biomarker,Increase risk
#215,dementia,Bullous pemphigoid,Condition,Increase risk
#435,AD,Cancer,Condition,Not significant
#566,AD,cancer,Condition,Decrease risk
#588,AD,Cannabinoids,Medication,Not significant
#566,AD,cardiovascular disease,Condition,Decrease risk
#294,dementia,cardiovascular risk factors,Condition,inconsistent
#423,dementia,cardiovascular risk factors,Condition,Increase risk
#452,Dementia,cardiovascular risk factors,Condition,Increase risk
#566,AD,carotid atherosclerosis,Condition,Increase risk
#435,AD,Carotid atherosclerosis ,Condition,Not significant
#854,AD,Cathepsins,Biomarker,Decrease risk
#891,Dementia,Cerebral Microbleeds,Condition,Not significant
#590,dementia,Cerebrolysin,Medication,decrease risk
#703,AD,Cerebrolysin,Medication,Decrease risk
#1046,AD,cerebrospinal fluid,Biomarker,Increase risk
#555,AD,cerebrospinal fluid,Biomarker,Increase risk
#520,AD,ChAT gene polymorphism,Genomic,increase risk
#520,AD,ChAT gene polymorphism,Genomic,not significant
#520,AD,ChAT gene polymorphism,Genomic,not significant
#520,AD,ChAT gene polymorphism,Genomic,increase risk
#435,AD,Cholesterol,Biomarker,Not significant
#435,VaD,Cholesterol,Biomarker,Not significant
#435,dementia,Cholesterol,Biomarker,Not significant
#477,AD,cholesterol,Biomarker,Increase risk
#974,AD,cholesterol,Biomarker,inconsistent
#1021,AD,Cholesterol,Condition,Increase risk
#530,AD,Cholinesterase inhibitors,Medication,decrease risk
#641,AD,cholinesterase inhibitors,Medication,Decrease risk
#814,AD,cholinesterase inhibitors,Medication,Decrease risk
#1071,dementia,Chronic Obstructive Pulmonary Disease (COPD),Condition,Increase risk
#392,Dementia,Chronic periodontal disease,Condition,Increase risk
#364,dementia,circulating metabolites,Biomarker,Increase risk
#408,Dementia,coffee,Life style,Not significant
#566,AD,coffee,life style,Decrease risk
#255,AD,Cognitive activity,Life style,inconsistent
#325,dementia,Cognitive activity,Life style,decrease risk
#566,AD,cognitive activity,Life style,Decrease risk
#593,AD,cognitive activity,Life style,Decrease risk
#746,AD,cognitive activity,Life style,Decrease risk
#435,AD,Cognitive engagement ,Life style,Not significant
#328,Dementia,cognitive training,Procedure,Not significant
#487,dementia,cognitively demanding leisure activities,Life style,Decrease risk
#441,Dementia,combination of modifiable risk factors,Life style,Increase risk
#567,AD,conjugated equine estrogen use with medroxyprogesterone acetate,Medication,Increase risk
#250,AD,conscientiousness,Life style,increase risk
#531,Dementia,coronary heart disease,Condition,Increase risk
#307,AD,CYP46A1 rs754203 polymorphism,Genomic,Not significant
#425,AD,daily listening to music,Life style,Decrease risk
#405,AD,D-dimer,Biomarker,Increase risk
#405,vascular dementia,D-dimer,Biomarker,Increase risk
#641,AD,Decreasing Amyloid-beta production,Medication,Not significant
#949,dementia,delirium,Condition,Increase risk
#1021,AD,Depression,Condition,Increase risk
#1021,Dementia,Depression,Condition,Increase risk
#1270,AD,Depression,Condition,Increase risk
#1270,dementia,depression,Condition,Increase risk
#1270,AD,Depression,Condition,Increase risk
#1270,Dementia,Depression,Condition,Increase risk
#1270,AD,depression,Condition,Increase risk
#164,Dementia,depression,Condition,Increase risk
#203,dementia,depression,Condition,Increase risk
#217,dementia,Depression,Condition,Increase risk
#345,dementia,Depression,Condition,increase risk
#352,Dementia,depression,Condition,Increase risk
#425,AD,depression,Condition,Increase risk
#426,dementia,depression,Condition,Increase risk
#487,dementia,depression,Condition,Increase risk
#502,dementia,Depression,Condition,Increase risk
#502,dementia,depression,Condition,Increase risk
#502,AD,depression,Condition,Increase risk
#502,Dementia,Depression,Condition,Increase risk
#502,AD,Depression,Condition,Increase risk
#502,dementia,depression,Condition,Increase risk
#502,AD,depression,Condition,Increase risk
#550,Dementia,depression,Condition,Increase risk
#550,Vascular dementia,depression,Condition,Increase risk
#550,AD,depression,Condition,Increase risk
#564,AD,Depression,Condition,inconsistent
#566,AD,depression,Condition,Increase risk
#655,dementia,Depression,Condition,inconsistent
#435,dementia,Depression ,Condition,Increase risk
#435,VaD,Depression ,Condition,Increase risk
#435,AD,Depression ,Condition,Increase risk
#213,dementia,Diabetes,Condition,Not significant
#217,dementia,Diabetes,Condition,Increase risk
#283,dementia,diabetes,Condition,Increase risk
#345,dementia,Diabetes,Condition,increase risk
#345,AD,Diabetes,Condition,decrease risk
#423,dementia,diabetes,Condition,Increase risk
#435,AD,Diabetes,Condition,Increase risk
#452,Dementia,Diabetes,Condition,Increase risk
#455,AD,Diabetes,Condition,Increase risk
#474,AD,diabetes,Condition,increase risk
#474,vascular dementia,diabetes,Condition,increase risk
#474,dementia,diabetes,Condition,increase risk
#487,dementia,diabetes,Condition,Increase risk
#564,AD,Diabetes,Condition,inconsistent
#435,dementia,Diabetes ,Condition,Increase risk
#435,VaD,Diabetes ,Condition,Increase risk
#567,AD,Diabetes ,Condition,Increase risk
#468,AD,Diastolic Hypertension,Condition,Not significant
#1021,AD,diet,Life style,Decrease risk
#1021,Dementia,Diet,Life style,Decrease risk
#298,Dementia,diet,Life style,Increase risk
#435,AD,diet,Life style,Not significant
#435,dementia,Diet,Life style,Not significant
#456,dementia,diet,Life style,decrease risk
#746,AD,diet,Life style,Decrease risk
#189,dementia,disrupted rest-activity rhythms (RARs),Biomarker,Increase risk
#487,dementia,diuretics,Medication,Decrease risk
#467,dementia,DNA Methylation Age,Genomic,Increase risk
#103,dementia,docosahexaenoic acid,Biomarker,not significant
#504,AD,donepezil,Medication,decrease risk
#504,AD,donepezil + memantine,Medication,Not significant
#345,AD,Dyslipidaemia,Condition,decrease risk
#144,dementia,education,Social economic status,decrease risk
#334,AD,education,Social economic status,Not significant
#372,dementia,education,Social economic status,decrease risk
#423,dementia,education,Social economic status,Increase risk
#435,Dementia,education,Social economic status,Decrease risk
#435,AD,education,Social economic status,Increase risk
#478,dementia,education,Social economic status,Decrease risk
#487,dementia,education,Social economic status,Increase risk
#564,AD,education,Social economic status,inconsistent
#566,AD,education,Social economic status,Increase risk
#567,AD,education,Social economic status,Decrease risk
#857,AD,Education,social economic status,increase risk
#972,dementia,education,Social economic status,increase risk
#103,dementia,eicosapentaenoic acid,Biomarker,Increase risk
#1051,AD,electromagnetic fields,Environment,Increase risk
#1058,AD,electromagnetic fields,Environment,Increase risk
#553,dementia,electromagnetic fields,Environment,Increase risk
#70,AD,electromagnetic fields,Environment,Increase risk
#240,Dementia,endogenous estrogen,Biomarker,Not significant
#555,AD,entorhinal atrophy,Condition,Increase risk
#345,dementia,Epilepsy,Condition,Not significant
#534,AD,epilepsy,Condition,Not significant
#1024,AD,essential oils,Medication,Increase risk
#566,AD,estrogen,Medication,Decrease risk
#82,dementia,estrogen plus progestin,Biomarker,decrease risk
#67,Dementia,estrogen plus progestin,Procedure,Increase risk
#572,AD,exercise,Life style,Decrease risk
#250,AD,extraversion,Life style,decrease risk
#405,vascular dementia,factor VIII,Biomarker,Increase risk
#681,AD,Family history of Parkinson's disease,Family history,not significant
#369,AD,FERMT2 polymorphism,Genomic,not significant
#405,vascular dementia,fibrinogen levels,Biomarker,Increase risk
#275,dementia,fish consumption,Life style,Decrease risk
#435,AD,fish consumption,Life style,Decrease risk
#522,AD,fish consumption,Life style,Decrease risk
#718,AD,fish consumption,Life style,Decrease risk
#566,AD,folate,Medication,Decrease risk
#1230,dementia,Frailty,Condition,Increase risk
#181,Dementia,frailty,Condition,Increase risk
#181,AD,frailty,Condition,Increase risk
#181,AD,frailty,Condition,Increase risk
#181,Vascular dementia,frailty,Condition,Increase risk
#566,AD,frailty,Condition,Increase risk
#504,AD,galantamine,Medication,decrease risk
#419,AD,GDNF-AS,Genomic,Increase risk
#396,AD,gene,Genomic,Increase risk
#377,AD,gene(A novel locus was uncovered on chromosome 4),Genomic,Increase risk
#334,AD,genes,Genomic,Not significant
#370,AD,Genetic risk scores,Genomic,Increase risk
#430,Dementia,Genetic variation in clusterin gene (CLU),Genomic,Increase risk
#425,AD,genetics,Genomic,Increase risk
#437,Dementia,Ginkgo biloba,Medication,Decrease risk
#1121,AD,Glaucoma,Condition,Increase risk
#409,Dementia,Glucocerebrosidase mutations,Genomic,Increase risk
#341,AD,Glutathione S-transferase,Genomic,Not significant
#341,AD,Glutathione S-transferase,Genomic,Not significant
#341,AD,Glutathione S-transferase,Genomic,Not significant
#341,AD,Glutathione S-transferase,Genomic,Not significant
#341,AD,Glutathione S-transferase,Genomic,Not significant
#480,dementia,grean tea intake,Life style,Decrease risk
#480,AD,grean tea intake,Life style,Decrease risk
#588,AD,Guanosine analogue antivirals,Medication,Not significant
#419,AD,HAO2-AS,Genomic,Increase risk
#239,dementia,Health illteracy,Social economic status,Increase risk
#280,AD,Hearing loss,Condition,Increase risk
#399,Dementia,hearing loss,Condition,Increase risk
#435,dementia,hearing loss,Condition,Increase risk
#561,dementia,Hearing loss,Condition,increase risk
#561,AD,Hearing loss,Condition,increase risk
#563,dementia,Hearing loss,Condition,increase risk
#531,Dementia,heart failure,Condition,Increase risk
#952,dementia,high fat intake,Life style,Increase risk
#555,AD,hippocampal atrophy,Condition,Increase risk
#381,AD,Homocysteine,Biomarker,increase risk
#435,AD,Homocysteine,Biomarker,Increase risk
#405,AD,Homocysteine ,Biomarker,Increase risk
#405,vascular dementia,Homocysteine ,Biomarker,Increase risk
#292,dementia,hormone therapy,Medication,Increase risk
#300,AD,hormone therapy,Medication,not significant
#435,AD,hormone therapy,Medication,Not significant
#5,Dementia,hormone therapy,Medication,Increase risk
#676,AD,Hormone therapy,Medication,inconsistent
#435,dementia,Hormones,Biomarker,Not significant
#435,AD,Hormones,Biomarker,Not significant
#683,AD,Huperzine A,Medication,inconsistent
#213,dementia,Hypercholesterolemia,Condition,Increase risk
#566,AD,hyperhomocysteine,Biomarker,Increase risk
#217,dementia,hyperlipidemia,Condition,Increase risk
#1021,Vascular Dementia,hypertension,Condition,Increase risk
#213,dementia,Hypertension,Condition,Not significant
#217,dementia,Hypertension,Condition,Increase risk
#281,vascular dementia,hypertension,Condition,increase risk
#281,vascular dementia,hypertension,Condition,increase risk
#345,vascular dementia,Hypertension,Condition,increase risk
#423,dementia,hypertension,Condition,Increase risk
#425,AD,hypertension,Condition,Increase risk
#435,VaD,hypertension,Condition,Increase risk
#435,AD,hypertension,Condition,Not significant
#487,dementia,hypertension,Condition,Increase risk
#564,AD,Hypertension,Condition,inconsistent
#566,AD,hypertension,Condition,Increase risk
#952,dementia,hypertension,Condition,Increase risk
#1230,dementia,Hypoglycemia,Condition,Increase risk
#218,dementia,Hypoglycemia,Condition,Increase risk
#655,dementia,Illiteracy,Social economic status,inconsistent
#435,dementia,inflammation,Biomarker,Not significant
#435,AD,inflammation,Biomarker,Not significant
#824,AD,inflammation,Condition,Increase risk
#466,dementia,insomnia,Condition,Increase risk
#568,AD,Insomnia,Condition,Increase risk
#568,AD,Insomnia,Condition,Not significant
#568,Vascular Dementia,Insomnia,Condition,Not significant
#435,dementia,Insulin sensitizers,Medication,Not significant
#435,AD,Insulin sensitizers,Medication,Not significant
#487,dementia,insulin sensitizers,Medication,Increase risk
#1264,AD,Intensive LDL-cholesterol lowering therapy,Medication,Decrease risk
#293,Dementia,Intraindividual variability (IIV),Condition,Increase risk
#947,AD,intravenous immunoglobulins,Procedure,Not significant
#891,Dementia,Lacunes of Presumed Vascular Origin,Condition,Increase risk
#334,AD,learning disability,Genomic,Not significant
#177,demenaia,Leisure activities,Life style,Not significant
#992,dementia,Leisure activities,Life style,decrease risk
#547,dementia,leisure time physical activity,Life style,Decrease risk
#547,AD,leisure time physical activity,Life style,Decrease risk
#655,AD,Leptin,Biomarker,inconsistent
#745,AD,Leptin,Biomarker,inconsistent 
#765,dementia,Life style/environment,Life style,inconsistent
#238,AD,lipid peroxidation,Biomarker,Increase risk
#249,AD,lithium,Medication,Decrease risk
#274,dementia,Living with others,Life style,inconsistent
#566,AD,low diastolic blood pressure,Condition,Increase risk
#423,dementia,low income,Social economic status,Increase risk
#1240,AD,lycopene,Medication,Decrease risk
#305,AD,Magnesium,Biomarker,Increase risk
#305,AD,Magnesium,Biomarker,Increase risk
#305,AD,Magnesium,Biomarker,inconsistent
#290,Dementia,mastication,Life style,Increase risk
#435,dementia,Medical Arthritis ,Condition,Not significant
#435,AD,Medical Arthritis ,Condition,Not significant
#274,dementia,Mediterranean diet,Life style,inconsistent
#482,Dementia,mediterranean diet,Life style,Decrease risk
#482,AD,mediterranean diet,Life style,Decrease risk
#487,AD,Mediterranean diet,Life style,Decrease risk
#487,dementia,Mediterranean diet,Life style,Decrease risk
#567,AD,Mediterranean diet,Life style,Decrease risk
#570,AD,Mediterranean diet,Life style,Decrease risk
#601,AD,Mediterranean diet,Life style,Decrease risk
#936,AD,Mediterranean diet,Life style,Decrease risk
#425,AD,meeting with friends weekly,Life style,Decrease risk
#645,AD,melatonin supplements,Medication,Decrease risk
#504,AD,Memantine,Medication,decrease risk
#530,AD,Memantine,Medication,decrease risk
#641,AD,Memantine,Medication,Decrease risk
#643,AD,Memantine,Medication,Decrease risk
#487,dementia,mental demands at the work place,Social economic status,Decrease risk
#150,AD,metabolic syndrome,Condition,inconsistent
#452,Dementia,Metabolic Syndrome,Condition,Increase risk
#566,AD,metabolic syndrome,Condition,Decrease risk
#986,dementia,Metabolic syndrome,Condition,Increase risk
#435,AD,Metabolic syndrome ,Condition,Not significant
#545,Dementia,Metformin,Medication,Decrease risk
#276,AD,methylenetetrahydrofolate reductase (MTHFR) gene C677T polymorphism,Genomic,Increase risk
#198,AD,microinfarcts,Condition,inconsistent
#198,vascular dementia,microinfarcts,Condition,inconsistent
#198,dementia,microinfarcts,Condition,inconsistent
#420,AD,Microinfarcts,Condition,increase risk
#13,Dementia,Mineral supplementation,Medication,Not significant
#310,AD,minor T allele of rs5848,Genomic,Increase risk
#1100,AD,mitochondria dysfunction and oxidative stress,Condition,Increase risk
#569,AD,Mn deficiency,Condition,Increase risk
#435,Dementia,motor function,Biomarker,Not significant
#818,dementia,motor function,Condition,Increase risk
#818,dementia,motor function,Condition,Not significant
#343,dementia with Lewy bodies (DLB),mutations in GBA1,Genomic,Increase risk
#419,AD,NDM29,Genomic,Increase risk
#250,AD,Neuroticism,Life style,increase risk
#173,AD,Nonsteroidal Anti-inflammatory Drugs,Medication,Not significant
#566,AD,nonsteroidal anti-inflammatory drugs,Medication,Decrease risk
#590,dementia,nootropic drugs(Citicoline),Medication,Not significant
#333,AD,NOS3 Glu298Asp,Genomic,Not significant
#889,AD,NRXN3,Genomic,Increase risk
#1021,AD,obesity,Condition,Increase risk
#202,Dementia,obesity,Condition,Increase risk
#479,dementia,Obesity,Condition,increase risk
#479,dementia,Obesity,Condition,increase risk
#487,dementia,obesity,Condition,Increase risk?
#538,AD,Obesity,Condition,Increase risk
#564,AD,Obesity,Condition,inconsistent
#952,dementia,obesity,Condition,Increase risk
#655,dementia,Occupation,Social economic status,inconsistent
#566,AD,occupational,Life style,Not significant
#103,dementia,Omega-3 Fatty Acids level,Biomarker,Increase risk
#573,dementia,Omega-3 Fatty Acids supplementation,Medication,Not significant
#718,AD,Omega-3 Fatty Acids supplementation,Medication,Not significant
#718,Dementia,Omega-3 Fatty Acids supplementation,Medication,Not significant
#793,dementia,Omega-3 Fatty Acids supplementation,Medication,Decrease risk
#824,AD,Omega-3 Fatty Acids supplementation,Medication,Not significant
#103,dementia,Omega-6 Fatty Acids level,Biomarker,not significant
#250,AD,openness,Life style,decrease risk
#535,dementia,oral anticoagulant (OAC),Medication,Decrease risk
#1130,dementia,Orthostatic Hypotension,Condition,Increase risk
#345,dementia,Orthostatic hypotension,Condition,increase risk
#345,AD,Orthostatic hypotension,Condition,increase risk
#391,Dementia,Orthostatic hypotension,Condition,Increase risk
#391,Dementia,orthostatic hypotension,Condition,Increase risk
#995,dementia,Orthostatic hypotension,Condition,Increase risk
#362,dementia,Osteoarthritis,Condition,Increase risk
#888,AD,Osteoporosis,Condition,Increase risk
#863,Dementia,over-the-Counter Supplement Interventions,Medication,Not significant
#345,dementia,Parkinson's disease,Condition,increase risk
#321,Dementia,Passive smoking,Life style,Not significant
#1124,Dementia,Periodontal Disease,Condition,Increase risk
#435,AD,Peripheral artery disease ,Condition,Not significant
#487,dementia,peripheral hearing loss,Condition,Inconsistent
#348,Dementia,Perivascular Spaces,Biomarker,Increase risk
#891,Dementia,Perivascular Spaces,Biomarker,Increase risk
#459,dementia,personality disorder,Condition,Not significant
#1051,AD,Pesticides,Environment,Increase risk
#1058,AD,Pesticides,Environment,Increase risk
#299,dementia,Pesticides,Environment,increase risk
#435,AD,Pesticides ,Environment,Not significant
#716,FTD,PGRNgene,Genomic,Increase risk
#435,AD,Pharmacological Antacids ,Medication,Not significant
#1021,AD,Physical Activity,Life style,Decrease risk
#1021,Dementia,Physical Activity,Life style,Decrease risk
#1021,Vascular Dementia,Physical Activity,Life style,Decrease risk
#214,AD,physical activity,Life style,decrease risk
#217,dementia,physical activity,Life style,increase risk
#448,dementia,physical activity,Life style,Not significant
#484,dementia,physical activity,Life style,Decrease risk
#564,AD,Physical activity,Life style,inconsistent
#593,AD,Physical Activity,Life style,Decrease risk
#746,AD,Physical Activity,Life style,Decrease risk
#945,vascular dementia,physical activity,Life style,decrease risk
#952,dementia,physical activity,Life style,Increase risk
#956,dementia,physical activity,Life style,decrease risk
#208,AD,Physical activity ,Life style,Increase risk
#435,dementia,Physical activity ,Life style,Decrease risk
#435,VaD,Physical activity ,Life style,Decrease risk
#435,AD,Physical activity ,Life style,Decrease risk
#487,dementia,Physical activity ,Life style,Decrease risk
#487,AD,Physical activity ,Life style,Decrease risk
#515,dementia,Physical activity ,Life style,Decrease risk
#554,dementia,Physical activity ,Life style,Not significant
#554,AD,Physical activity ,Life style,Not significant
#626,dementia,Physical activity ,Life style,Not significant
#567,AD,physically and cognitively stimulating activities,Life style,Decrease risk
#833,AD,plants used in indian medicine,Medication,Not significant
#764,dementia,plasma high-density lipoprotein cholesterol (HDL-C),Biomarker,Not significant
#234,AD,plasma testosterone level,Biomarker,Increase risk
#405,AD,plasminogen activator inhibitor-1,Biomarker,Increase risk
#1258,dementia,PM2.5,Environment,Increase risk
#1224,AD,polyphenols,Medication,Not significant
#438,AD,polyphenols,Medication,Not significant
#780,dementia,Poor Gait Performance,Condition,Increase risk
#445,dementia,postoperative delirium after hip surgery,Condition,Increase risk
#502,dementia,Post-traumatic stress disorder (PTSD),Condition,Not significant
#502,dementia,Post-traumatic stress disorder (PTSD),Condition,Not significant
#502,Dementia,Post-traumatic stress disorder (PTSD),Condition,Not significant
#502,dementia,Post-traumatic stress disorder (PTSD),Condition,Not significant
#185,AD,Prion protein gene polymorphism,Genomic,inconsistent
#1047,Dementia,Proton-pump inhibitors,Medication,Not significant
#366,AD,PTGS2 rs20417,Genomic,Increase risk
#74,AD,raloxifene,Medication,Decrease risk
#435,AD,Renal Disease,Condition,Not significant
#87,AD,renin-angiotensin system blockade,Medication,decrease risk
#278,Dementia,retinal microvascular changes,Condition,Increase risk
#1067,AD,retinal spectral-domain (SD) OCT measurement,Biomarker,Increase risk
#504,AD,rivastigmine,Medication,decrease risk
#424,AD,rs11136000 CLU,Genomic,Increase risk
#359,AD,rs1467967A/G,Genomic,Not significant
#359,AD,rs242557G/A,Genomic,Decrease risk
#359,AD,rs2471738C/T,Genomic,Not significant
#424,AD,rs3764650 ABCA7,Genomic,Increase risk
#359,AD,rs3785883G/A,Genomic,Not significant
#256,AD,rs4646953,Genomic,not significant
#256,AD,"rs4646953, rs2251101 and rs1544210",Genomic,not significant
#424,AD,rs610932 MS4A6A,Genomic,Increase risk
#424,AD,rs6656401 CR1,Genomic,Increase risk
#359,AD,rs7521G/A,Genomic,Not significant
#296,AD,Saitohin Q7R polymorphism,Genomic,Increase risk
#435,AD,Serum uric acid,Condition,Not significant
#157,dementia,sex,Demographic,Increase risk
#386,FTD,sex,Demographic,Not significant
#655,dementia,sex,Demographic,inconsistent
#952,dementia,sex,Demographic,Increase risk
#565,AD,sleep disturbances,Condition,Increase risk
#568,Dementia,Sleep Disturbances,Condition,Increase risk
#568,AD,Sleep Disturbances,Condition,Increase risk
#568,Vascular Dementia,Sleep Disturbances,Condition,Increase risk
#568,Dementia,sleep disturbances,Condition,Increase risk
#568,AD,sleep disturbances,Condition,Increase risk
#568,Vascular Dementia,sleep disturbances,Condition,Increase risk
#435,dementia,sleep duration,Life style,Increase risk
#435,AD,sleep duration,Life style,not significant
#501,Dementia,Sleep-disordered breathing,Condition,Increase risk
#1021,AD,Smoking,Life style,Increase risk
#1021,Dementia,Smoking,Life style,Increase risk
#1021,Vascular Dementia,Smoking,Life style,Increase risk
#208,AD,smoking,Life style,Increase risk
#213,dementia,Smoking,Life style,inconsistent 
#217,dementia,Smoking,Life style,Increase risk
#274,dementia,Smoking,Life style,inconsistent
#564,AD,Smoking,Life style,inconsistent
#566,AD,smoking,Life style,Decrease risk
#567,AD,smoking,Life style,Increase risk
#655,dementia,Smoking,Life style,inconsistent
#668,AD,smoking,Life style,Increase risk
#934,AD,smoking,Life style,Increase risk
#934,Dementia,smoking,Life style,Increase risk
#952,dementia,smoking,Life style,Increase risk
#435,dementia,Smoking ,Life style,Increase risk
#435,VaD,Smoking ,Life style,Increase risk
#435,AD,Smoking ,Life style,Increase risk
#593,AD,social engagement,Condition,Decrease risk
#435,dementia,social engagement,Life style,Increase risk
#487,dememtia,social engagement,Life style,Decrease risk
#551,dementia,social engagement,Life style,Increase risk
#567,AD,social engagement,Social economic status,Increase risk
#655,dementia,Socioeconomic status,Social economic status,inconsistent
#1058,AD,Solvents,Environment,Increase risk
#419,AD,Sox2OT,Genomic,Increase risk
#588,AD,SSRIs,Medication,Not significant
#245,AD,statin,Medication,not significant
#314,Dementia,statin,Medication,Decrease risk
#314,AD,statin,Medication,Decrease risk
#315,vascular dementia,statin,Medication,inconsistent
#41,dementia,statin,Medication,Not significant
#435,dementia,statin,Medication,Decrease risk
#435,AD,statin,Medication,Decrease risk
#566,AD,statin,Medication,Decrease risk
#567,AD,statin,Medication,Decrease risk
#592,AD,statin,Medication,decrease risk
#640,Dementia,statin,Medication,Decrease risk
#705,Dementia,statin,Medication,Not significant
#721,Dementia,statin,Medication,Decrease risk
#939,AD,statin,Medication,Not significant
#566,AD,stress,Condition,Decrease risk
#1260,dementia,stroke,Condition,Increase risk
#345,dementia,Stroke,Condition,increase risk
#345,vascular dementia,Stroke,Condition,increase risk
#345,AD,Stroke,Condition,decrease risk
#410,Dementia,Stroke,Condition,Increase risk
#559,dementia,stroke,Condition,Increase risk
#952,dementia,stroke,Condition,Increase risk
#747,Dementia,subclinical hypothyroidism (sHT),Condition,Not significant
#468,AD,systolic hypertension,Condition,Increase risk
#555,AD,Tau,Biomarker,Increase risk
#868,AD,Tau,Biomarker,increase risk
#868,AD,Tau,Biomarker,Not significant
#868,AD,Tau,Biomarker,increase risk
#868,AD,Tau,Biomarker,increase risk
#1078,AD,telomere length,Genomic,Increase risk
#368,AD,Telomere length,Genomic,Increase risk
#473,AD,telomere length,Genomic,Increase risk
#571,AD,the neurological and immune-mediated disease haplotype HLA-DR15,Biomarker,Increase risk
#856,AD,therapeutic potential of vaccines,Medication,Not significant
#405,AD,thrombomodulin,Biomarker,Increase risk
#251,AD,TNF-a promoter 2308 A/G polymorphism,Genomic,Increase risk
#392,Dementia,Tooth loss,Condition,Increase risk
#398,dementia,Tooth loss,Condition,increase risk
#891,Dementia,Total Cerebral Atrophy,Condition,Increase risk
#553,dementia,toxic heavy metals,Environment,Increase risk
#1105,AD,Toxoplasma infection,Condition,Not significant
#42,Vascular dementia,Traditional Chinese herbal medicine (TCHM),Medication,Not significant
#1127,dementia,traumatic brain injury,Condition,Increase risk
#346,Dementia,traumatic brain injury,Condition,Not significant
#421,dementia,traumatic brain injury,Condition,Increase risk
#428,AD,traumatic brain injury,Condition,Not significant
#435,dementia,traumatic brain injury,Condition,Not significant
#435,AD,traumatic brain injury,Condition,Not significant
#449,dementia,traumatic brain injury,Condition,not significant
#449,AD,traumatic brain injury,Condition,increase risk
#454,dementia,traumatic brain injury,Condition,Increase risk
#487,dementia,traumatic brain injury,Condition,Increase risk
#567,AD,traumatic brain injury,Condition,Increase risk
#685,dementia,traumatic brain injury,Condition,inconsistent
#691,dementia,traumatic brain injury,Condition,Not significant
#952,dementia,traumatic brain injury,Condition,Increase risk
#17,dementia,treatment of Type 2 diabetes(glycaemic control),Medication,Increase risk
#387,AD,TREM2 variants,Genomic,Increase risk
#440,AD,TREM2 variants,Genomic,Increase risk
#111,dementia,type 2 diabetes mellitus,Condition,Increase risk
#208,AD,type 2 diabetes mellitus,Condition,Increase risk
#282,AD,type 2 diabetes mellitus,Condition,Increase risk
#512,dementia,type 2 diabetes mellitus,Condition,Increase risk
#566,AD,type 2 diabetes mellitus,Condition,Increase risk
#621,AD,type 2 diabetes mellitus,Condition,Increase risk
#621,Vascular dementia,type 2 diabetes mellitus,Condition,Increase risk
#831,AD,type 2 diabetes mellitus,Condition,Increase risk
#831,vascular dementia,type 2 diabetes mellitus,Condition,Increase risk
#952,dementia,type 2 diabetes mellitus,Condition,Increase risk
#318,AD,Val66Met polymorphism,Genomic,Not significant
#716,FTD,Valosin Containing Protein(VCP) Gene Mutations,Genomic,Increase risk
#213,dementia,vascular risk factors,Condition,Not significant
#226,dementia,Vegetable consumption,Life style,decrease risk
#197,AD,Vitamin A supplementation,Medication,decrease risk
#935,dementia,Vitamin B deficiency,Condition,Not significant
#1073,Dementia,vitamin B supplementation,Medication,Not significant
#588,AD,vitamin B supplementation,Medication,Not significant
#244,dementia,Vitamin C supplementation,Medication,Decrease risk
#566,AD,vitamin C supplementation,Medication,Decrease risk
#188,dementia,vitamin d deficiency,Condition,increase risk
#335,dementia,vitamin d deficiency,Condition,Increase risk
#553,dementia,vitamin d deficiency,Condition,Increase risk
#156,Dementia,vitamin d level,Biomarker,Increase risk
#557,dementia,vitamin d level,Biomarker,Increase risk
#557,AD,vitamin d level,Biomarker,Increase risk
#244,dementia,vitamin E supplementation,Medication,Decrease risk
#35,Dementia,vitamin E supplementation,Medication,Not significant
#425,AD,vitamin E supplementation,Medication,Decrease risk
#489,AD,vitamin E supplementation,Medication,Not significant
#566,AD,vitamin E supplementation,Medication,Decrease risk
#13,Dementia,Vitamin supplementation,Medication,Not significant
#405,AD,Von Willebrand factor,Biomarker,Increase risk
#405,vascular dementia,Von Willebrand factor,Biomarker,Increase risk
#259,dementia,White matter hyperintensities,Biomarker,Increase risk
#420,AD,White matter hyperintensities,Biomarker,decrease risk
#950,dementia,White matter hyperintensities,Biomarker,Increase risk
#322,dementia,White matter Hyperintensities,Condition,Increase risk
#322,AD,White matter Hyperintensities,Condition,Increase risk
#891,Dementia,White Matter Hyperintensities,Condition,Increase risk
#891,AD,White Matter Hyperintensities,Condition,Increase risk
#891,Vascular Dementia,White Matter Hyperintensities,Condition,Increase risk
#915,Dementia,White matter hyperintensities,Condition,Increase risk
#915,AD,White matter hyperintensities,Condition,Increase risk
#34,dementia,withdrawing antihypertensive medications,Medication,Not significant
#219,dementia,Year,Demographic,not significant
#1143,Dementia,yoga,Life style,Decrease risk
#821,dementia,yoga,Life style,Not significant
#821,AD,yoga,Life style,Not significant
#340,AD,Zinc,Biomarker,inconsistent